Latest filing published 30 Jun 2026 for BioAge Labs, Inc., €446k.
Barton Shane appears in our data through filings on BioAge Labs, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 29 June 2026 and the latest from 30 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 30 June 2026, the filings show a transaction worth €446k in BioAge Labs, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations